Pharmacoeconomic Considerations in Pharmaceutical Company Promotions-Reply
Richard Levy, PhD
Arch Fam Med. 1994;3(12):1035.
Article references have been provided for searching and linking. Additional reference information may be available in the article PDF.
1. Levy RA. Pharmaceutical Research: Therapeutic and Economic Value of Incremental Improvements. Reston, Va: National Pharmaceutical Council; 1990.
2. Yasuda SA, Woosley RL. The clinical value of FDA class C drugs approved from 1981 to 1988. Clin Pharmacol Ther. 1992;52:577-582.